Cathay Capital invests in Echosens
Cathay Capital Private Equity said Wednesday it invested in Echosens. Financial terms weren't announced. FuRui Group, the seller, will retain a majority holding of 51 percent. Echosens, of France, develops non-invasive diagnostic products and services for hepatology.




